Karen Teuwen, CFA

Entrepreneur Passionate about Empowering Start-ups and Crafting Effective Business Strategies | Country Manager | Impact Investor

📍 Brazil🔄 Updated October 2026💼 1 investments📅 4 years investing🗓 Last invested Sep 2022
VC🌍 Brazil
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Member & Angel Investor
Sep 2022
A missão do Sororitê é trazer mais capital para startups excepcionais lideradas por mulheres. Para alcançar esse objetivo, contamos com dois pilares fundamentais: O Sororite Angel Network é a maior rede de mulheres investidoras-anjo do Brasil, composta por mulheres visionárias que investem coletivamente em startups lideradas por empreendedoras. O Sororitê Ventures é um fundo de venture capital pre-seed de U$5 milhões dedicado a investir em startups brasileiras com diversidade no time de fundadores. Estamos comprometidas em promover um ecossistema mais inclusivo e equitativo, onde o empreendedorismo e liderança feminina sejam reconhecidos e valorizados. Se você é uma fundadora e quer falar conosco, inscreva-se aqui: https://airtable.com/applPwuoWFzCPPooF/shrjkQZ3p1jiPMYbP Se você quer se tornar uma investidora da rede Sororitê, inscreva-se aqui: https://airtable.com/applPwuoWFzCPPooF/shrEonNvmIhoailFY
Experience · 5 entries
All (5)
Investments (1)
Founder (1)
2025
Co-Founder
Jul 2025
NeoCell Therapeutics is developing breakthrough 3D biomimetic technology to produce high-quality blood stem cells in vitro for cancer therapy. Our proprietary platform mimics the native bone marrow microenvironment, enabling scalable stem cell expansion while preserving regenerative potential - solving a critical bottleneck in the field. With blood cancer incidence rising 3-5% annually and only 30% of patients finding optimal donors, NeoCells technology delivers immediate availability, higher compatibility, and reduced toxicity compared to current treatment options. Our platform eliminates the 3-6 month donor search timeline, providing life-saving solutions when patients need them most. We are targeting umbilical cord blood banks seeking to enhance their therapeutic offerings and specialized cancer treatment centers requiring on-demand access to expanded stem cell populations. Our artificial bone marrow model maintains stem cell potency during long-term culture, addressing core commercialization challenges that competitors using small molecule approaches have struggled to overcome. NeoCell is advancing toward clinical proof-of-concept with plans to establish regulatory pathways and strategic partnerships across the Americas and Europe, positioning to transform blood stem cell therapy for cancer patients worldwide. Revolutionizing cancer treatment through innovative stem cell technology.
Entrepreneur in Residence
Feb 2025
Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 27 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel and seed-stage investor.
2022
Member & Angel Investor
Sep 2022
A missão do Sororitê é trazer mais capital para startups excepcionais lideradas por mulheres. Para alcançar esse objetivo, contamos com dois pilares fundamentais: O Sororite Angel Network é a maior rede de mulheres investidoras-anjo do Brasil, composta por mulheres visionárias que investem coletivamente em startups lideradas por empreendedoras. O Sororitê Ventures é um fundo de venture capital pre-seed de U$5 milhões dedicado a investir em startups brasileiras com diversidade no time de fundadores. Estamos comprometidas em promover um ecossistema mais inclusivo e equitativo, onde o empreendedorismo e liderança feminina sejam reconhecidos e valorizados. Se você é uma fundadora e quer falar conosco, inscreva-se aqui: https://airtable.com/applPwuoWFzCPPooF/shrjkQZ3p1jiPMYbP Se você quer se tornar uma investidora da rede Sororitê, inscreva-se aqui: https://airtable.com/applPwuoWFzCPPooF/shrEonNvmIhoailFY
2007
Associate, Equity Derivatives Sales
Jun 2007
ING With 9 million account holders, ING is one of the largest and most prominent financial service providers in the Netherlands. We are part of ING Group, a global financial institution. ING Group has clients in more than 40 countries in Europe, North America, Latin America, Asia and Australia. Ambition and agile way of working Our ambition is to help build a financially healthy and sustainable society for the Netherlands, for its residents and for its institutions. We want to lead the way in this. Where we once had large departments and traditional hierarchies, we now work in independent, multidisciplinary squads of about 9 colleagues. These squads (start-ups) work agile and are end-to-end responsible for all our new products and services. From design to delivery. Purpose INGs purpose is empowering people to stay a step ahead in life and in business. This purpose guides us in everything we do. ‘do your thing’ is our new brand direction and our first global tagline. It articulates our purpose and our promise to make banking frictionless.
2002
Research Associate, Financial Services Practice
Apr 2002
This page is no longer active. Follow the Gartner page for updates. About CEB, Now Gartner: Leading organizations worldwide rely on CEB services to harness their untapped potential and grow. Now offered by Gartner, CEB best practices and technology solutions equip clients with the intelligence to effectively manage talent, customers, and operations. More information is available at gartner.com/ceb. About Gartner: Gartner, Inc. (NYSE: IT), is the world’s leading research and advisory company and a member of the S&P 500. We equip business leaders with indispensable insights, advice tools to achieve their mission-critical priorities today and build the successful organizations of tomorrow. Our unmatched combination of expert-led, practitioner-sourced and data-driven research steers clients toward the right decisions on the issues that matter most. We’re trusted as an objective resource and critical partner by more than 12,000 organizations in more than 100 countries — across all major functions, in every industry and enterprise size. To learn more about how we help decision makers fuel the future of business, visit gartner.com.